When we applied DGCA to the RNA-seq data from the TCGA breast cancer samples with and without p53 mutations, we identified p53 pathway genes that had significant changes in correlation with TP53 between the p53-mutated samples and those without p53 mutations. This evidence concerns the gene TP53 and breast cancer.